-
Mylan launches generic contraceptive
PITTSBURGH — Mylan has launched a generic version of a Johnson & Johnson contraceptive, the company said Wednesday.
Mylan announced the launch of norethindrone tablets in the 0.35 mg strength. The drug is a generic version of Micronor, made by J&J subsidiary Janssen Pharmaceuticals. A company partnering with Mylan on the drug, Famy Care, received approval from the Food and Drug Administration for the drug.
Various versions of the drug had sales of about $57.2 million during the 12-month period that ended in March, according to IMS Health.
-
Impax Labs' president, CEO Larry Hsu to retire
HAYWARD, Calif. — The head of generic drug maker Impax Labs will retire, the company said Tuesday.
Impax said president and CEO Larry Hsu would retire, but would remain with the company until a replacement CEO is found and he would remain as a board member following the appointment of his successor. Hsu cofounded the company in 1994.
A three-person search committee to find a new CEO will include Hsu, Allen Chao and board chairman Bob Burr.